Comprehensive guide to severe asthma & biologics. Expert-written information on symptoms, diagnosis, treatment options, and prevention strategies for better respiratory health.
Severe asthma affects 5-10% of asthmatics but causes disproportionate morbidity. Biologic therapies targeting specific inflammatory pathways have revolutionized treatment for appropriate patients.
All information provided in this guide is reviewed by board-certified physicians and medical professionals at Chest Clinic of Kathmandu. We are committed to providing accurate, up-to-date medical information based on current clinical guidelines.
Biologics are monoclonal antibodies targeting specific inflammatory pathways. They block IgE, reduce eosinophils, or inhibit inflammatory cytokines, significantly reducing exacerbations in selected patients.
Biologics are typically long-term treatments. Response appears within 4-16 weeks. If effective, treatment continues; some patients may try discontinuation after sustained control.
Medical information verified by specialists
Content reviewed for accuracy
Based on current medical guidelines
Our expert team at Chest Clinic of Kathmandu is here to provide personalized medical advice and treatment options.
Book Consultation